A Look At Amdocs (DOX) Valuation After Softer 2026 Guidance And CEO Succession Plan

Amdocs (DOX) is back in the spotlight after issuing softer full year 2026 guidance, pairing it with a planned CEO transition and fresh customer and product updates that leave investors weighing execution risk more carefully.

See our latest analysis for Amdocs.

The recent guidance cut and CEO succession announcement have been accompanied by weaker momentum, with a 7 day share price return of 10.5% and a 90 day share price return of 14.21%. This has contributed to a 1 year total shareholder return of 12.57% and a 3 year total shareholder return of 18.32%, even after buybacks and dividend increases.

If this mix of telecom software, AI themes, and execution risk has your attention, you may want to see what else is out there via our screener of 33 AI infrastructure stocks.

So with Amdocs trading at US$73.34, sitting at a 30% discount to the average analyst price target and an estimated 47% intrinsic discount, is this recent pullback a chance to enter the stock, or is the market already accounting for future growth?

Advertisement

Most Popular Narrative: 23.2% Undervalued

At a last close of $73.34 versus a narrative fair value of $95.50, Amdocs is framed as materially undervalued while still facing measured growth expectations and tightening FY26 guidance.

The accelerating adoption of cloud, automation, and AI/ML across telecom and media sectors is driving a multi-year wave of IT stack modernization, with Amdocs winning new large-scale modernization and migration deals in cloud, generative AI, and data services. This is expanding its total addressable market and supporting sustained topline revenue growth.

Read the complete narrative.

Curious what kind of revenue trends, margin shifts, and future earnings multiple need to line up for that fair value to hold up? The narrative walks through a detailed set of forecasts and required assumptions that connect FY26 guidance, longer term earnings targets, and the discount rate into one cohesive valuation story.

Result: Fair Value of $95.50 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, slower than expected scaling in cloud and GenAI services, combined with Amdocs reliance on a small group of major telecom clients, could put pressure on this thesis.

Find out about the key risks to this Amdocs narrative.

Build Your Own Amdocs Narrative

If you look at this and think the assumptions do not quite fit your view, you can test the data yourself, adjust the story, and Do it your way in just a few minutes.

A good starting point is our analysis highlighting 5 key rewards investors are optimistic about regarding Amdocs.

Looking for more investment ideas?

If Amdocs has you thinking more broadly about where to put your money to work, do not stop here. Widen your search now and keep your options open.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

MI
mitchell_lawler
mitchell_lawler

Moderna nearly tripled overnight, and every other mRNA stock jumped with it. I think that could be a trap.

Moderna nearly tripled overnight, and every other mRNA stock jumped with it. I think that could be a trap. cover
138
PR
pri_dlp7z

Happy for the melanoma patients. It is no surprise that other companies moved up too. It's the optionality getting priced in.

QU
Quantanium

There’s a 60% to 85% probability of the vaccine being approved based on historical drug development data. Could be a lot of scrutiny by the FDA due to the novel platform used.

Market might be getting a little ahead of itself here.

About NasdaqGS:DOX

Amdocs

Through its subsidiaries, provides software and services to communications, entertainment, media, and other service providers worldwide.

Undervalued established dividend payer.

Advertisement

Weekly Picks

RI
Rick_Orford
FJET logo
Rick_Orford on Starfighters Space ·

The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market

Fair Value:US$520.6% undervalued
54 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
JO
John_Eric
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.9% undervalued
99 users have followed this narrative
2 users have commented on this narrative
15 users have liked this narrative
RC
PYPL logo
rcb9 on PayPal Holdings ·

Ten Percent More Volume, One Percent More Transaction Margin

Fair Value:US$70.8913.6% undervalued
13 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
HE
HedgeY
MU logo
HedgeY on Micron Technology ·

Micron - The Memory Bottleneck Behind the AI Supercycle

Fair Value:US$1.25k25.0% undervalued
38 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative

Updated Narratives

DA
AIIO logo
david_1211213 on Robo.ai ·

Robo.ai (AIIO): A Long-Term Bullish Technical Setup

Fair Value:US$5.6449.8% undervalued
1 users have followed this narrative
7 users have commented on this narrative
1 users have liked this narrative
RO
RockeTeller
WRLG logo
RockeTeller on West Red Lake Gold Mines ·

This Junior Gold Mine Just Hit Commercial Production, 120k oz Roadmap at $7,000 Gold

Fair Value:CA$4.3681.4% undervalued
27 users have followed this narrative
8 users have commented on this narrative
0 users have liked this narrative
AS
AstrisCorporateAdvisory
9436 logo
AstrisCorporateAdvisory on Okinawa Cellular Telephone ·

Mobile strategy pays off as churn falls

Fair Value:JP¥3.26k23.3% overvalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
331 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9115.3% overvalued
184 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0944.0% undervalued
209 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative